Literature DB >> 24374377

Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.

Souvik Karmakar1, Weidong Zhang1, Gul Ahmad2, Mayeen U Alam1, Richard Winn1, Workineh Torben3, Loc Le1, Kory A Tillery1, Afzal A Siddiqui4.   

Abstract

Sm-p80, the large subunit of Schistosoma masoni calpain, is a leading antigen candidate for a schistosome vaccine. Prophylactic and antifecundity efficacy of Sm-p80 has been tested using a variety of vaccine approaches. However, the mechanism of Sm-p80-mediated killing is still unknown. In this study, potential role of complement in Sm-p80-mediated protection was studied using both in vitro (cobra venom factor inhibition) and in vivo using mice deficient in C3 (C3 -/-; B6.129S4-C3tm1Crr/J). In the absence of C3, Sm-p80-based vaccine was able to provide significant reduction in adult worm burden following challenge with schistosome cercariae in mice suggesting the effector functions of complement may be limited in this vaccine-induced protection.

Entities:  

Keywords:  Schistosoma; Sm-p80; calpain; complement; schistosomiasis; vaccine

Mesh:

Substances:

Year:  2013        PMID: 24374377      PMCID: PMC4130258          DOI: 10.4161/hv.27576

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  48 in total

Review 1.  Schistosomiasis.

Authors:  Allen G P Ross; Paul B Bartley; Adrian C Sleigh; G Richard Olds; Yuesheng Li; Gail M Williams; Donald P McManus
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Proteins exposed at the adult schistosome surface revealed by biotinylation.

Authors:  Simon Braschi; R Alan Wilson
Journal:  Mol Cell Proteomics       Date:  2005-11-03       Impact factor: 5.911

3.  A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Authors:  George W Buchman; Matthew E Cohen; Yuhong Xiao; Nicola Richardson-Harman; Peter Silvera; Louis J DeTolla; Heather L Davis; Roselyn J Eisenberg; Gary H Cohen; Stuart N Isaacs
Journal:  Vaccine       Date:  2010-07-24       Impact factor: 3.641

4.  Regulation of the B cell response to T-dependent antigens by classical pathway complement.

Authors:  M B Fischer; M Ma; S Goerg; X Zhou; J Xia; O Finco; S Han; G Kelsoe; R G Howard; T L Rothstein; E Kremmer; F S Rosen; M C Carroll
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

5.  Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Janet Pompa; Rachael M Villalovos; Michelle Paz
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

6.  Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Zahid Noor; Afzal A Siddiqui
Journal:  Int J Infect Dis       Date:  2010-07-13       Impact factor: 3.623

7.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis.

Authors:  Anne Camille La Flamme; Andrew S MacDonald; Clive R Huxtable; Michael Carroll; Edward J Pearce
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.

Authors:  G Ahmad; W Torben; W Zhang; M Wyatt; A A Siddiqui
Journal:  Parasite Immunol       Date:  2009-03       Impact factor: 2.280

Review 10.  Time to set the agenda for schistosomiasis elimination.

Authors:  David Rollinson; Stefanie Knopp; Sarah Levitz; J Russell Stothard; Louis-Albert Tchuem Tchuenté; Amadou Garba; Khalfan A Mohammed; Nadine Schur; Bobbie Person; Daniel G Colley; Jürg Utzinger
Journal:  Acta Trop       Date:  2012-05-10       Impact factor: 3.112

View more
  1 in total

Review 1.  Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Authors:  Cristina Toscano Fonseca; Sergio Costa Oliveira; Clarice Carvalho Alves
Journal:  Front Immunol       Date:  2015-03-09       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.